- Home
- FULC vs GNE Comparison
FULC vs GNE Comparison
Compare FULC & GNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- GNE
- Stock Information
- Founded
- FULC 2015
- GNE 2011
- Country
- FULC United States
- GNE United States
- Employees
- FULC N/A
- GNE N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- GNE Power Generation
- Sector
- FULC Health Care
- GNE Utilities
- Exchange
- FULC Nasdaq
- GNE Nasdaq
- Market Cap
- FULC 372.2M
- GNE 419.3M
- IPO Year
- FULC 2019
- GNE N/A
- Fundamental
- Price
- FULC $7.44
- GNE $14.92
- Analyst Decision
- FULC Buy
- GNE
- Analyst Count
- FULC 8
- GNE 0
- Target Price
- FULC $7.13
- GNE N/A
- AVG Volume (30 Days)
- FULC 398.4K
- GNE 155.7K
- Earning Date
- FULC 11-12-2025
- GNE 11-05-2025
- Dividend Yield
- FULC N/A
- GNE 2.01%
- EPS Growth
- FULC N/A
- GNE 4.51
- EPS
- FULC N/A
- GNE 0.31
- Revenue
- FULC N/A
- GNE $456,876,000.00
- Revenue This Year
- FULC N/A
- GNE $14.60
- Revenue Next Year
- FULC N/A
- GNE $8.64
- P/E Ratio
- FULC N/A
- GNE $48.68
- Revenue Growth
- FULC 2752.05
- GNE 3.75
- 52 Week Low
- FULC $2.32
- GNE $13.05
- 52 Week High
- FULC $8.50
- GNE $28.47
- Technical
- Relative Strength Index (RSI)
- FULC 59.83
- GNE 34.28
- Support Level
- FULC $6.69
- GNE $14.73
- Resistance Level
- FULC $7.50
- GNE $15.14
- Average True Range (ATR)
- FULC 0.40
- GNE 0.33
- MACD
- FULC 0.07
- GNE 0.19
- Stochastic Oscillator
- FULC 71.38
- GNE 25.83
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About GNE Genie Energy Ltd. Class B Stock
Genie Energy Ltd, through its subsidiaries, operates as a retail energy provider. It serves two reportable business segments: Genie retail energy, or GRE, and Genie renewables. The Genie retail energy segment resells energy to residential and commercial consumers in the Eastern and Midwestern United States through its portfolio of various retail energy providers. The Genie renewables segment holds controlling interests in various companies engaged in the manufacturing of solar panels, solar installation design, and solar energy project management. It generates the majority of its revenue from the Genie retail energy segment.